✦ LIBER ✦

Alteration of beta-2-microglobulin level in malignant lymphoproliferative diseases after a high dose of alpha-2-recombinant interferon

✍ Scribed by Opat, Pavel; Drbal, Josef; Tauer, Zdeněk; Wotke, Richard

Book ID: 122586122
Publisher: Elsevier Science
Year: 1988
Weight: 422 KB
Volume: 24
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(88)90218-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of high-dose infusional hy

Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-α-2a in patients with advanced malignancies

✍ Scott Wadler; Hilda Haynes; Richard Schechner; Alla Rozenblit; Peter H. Wiemik 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 547 KB

Clinical results of two different dose r

Clinical results of two different dose regimens with high-dose interferon-alpha and interleukin-2 in advanced renal cell cancer and malignant melanoma

✍ K. Fenchel; A. Winkler; PS. Mitrou; D. Hoelzer; L. Bergmann 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Recombinant alpha-2b-interferon enhances

Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies

✍ Giovanni Scambia; Pierluigi Benedetti Panici; Stefano Iacobelli; Gabriela Baiocc 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 3 views

The circulating levels of a 90-kilodalton (K) tumor-associated antigen were measured in the blood of 43 patients with gynecologic and breast malignancies who underwent a short course of recombinant alpha-2b-interferon (rIFN a-zb) (3 million U/m2/d intramuscularly [IM] for 3 days). Of the 43 patients

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Prediction of sustained response to low-

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation

✍ Hideyuki Tamai; Naoki Shingaki; Tatsuya Shiraki; Hiroshi Tukuda; Yoshiyuki Mori; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Immune modulation of minimal residual di

Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia : A randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factor

✍ Jorge Cortes; Alfonso Quintás-Cardama; Dan Jones; Farhad Ravandi; Guillermo Garc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB